For: | Agarkov AA, Popova TN, Boltysheva YG. Influence of 10-(6-plastoquinonyl) decyltriphenylphosphonium on free-radical homeostasis in the heart and blood serum of rats with streptozotocin-induced hyperglycemia. World J Diabetes 2019; 10(12): 546-559 [PMID: 31915517 DOI: 10.4239/wjd.v10.i12.546] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/546.htm |
Number | Citing Articles |
1 |
Diana Alemán-González-Duhart, Samuel Álvarez-Almazán, Miguel Valdes, Feliciano Tamay-Cach, Jessica Elena Mendieta-Wejebe, Stéphane Mandard. In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents. PPAR Research 2021; 2021: 1 doi: 10.1155/2021/5100531
|
2 |
Monika Barteková, Adriana Adameová, Anikó Görbe, Kristína Ferenczyová, Oľga Pecháňová, Antigone Lazou, Naranjan S. Dhalla, Péter Ferdinandy, Zoltán Giricz. Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases. Free Radical Biology and Medicine 2021; 169: 446 doi: 10.1016/j.freeradbiomed.2021.03.045
|
3 |
Yuliya Dvoretskaya, Victor Glanz, Mariya Gryaznova, Mikhail Syromyatnikov, Vasily Popov. Mitochondrial Antioxidant SkQ1 Has a Beneficial Effect in Experimental Diabetes as Based on the Analysis of Expression of microRNAs and mRNAs for the Oxidative Metabolism Regulators. Antioxidants 2021; 10(11): 1749 doi: 10.3390/antiox10111749
|
4 |
Francesca Forini, Paola Canale, Giuseppina Nicolini, Giorgio Iervasi. Mitochondria-Targeted Drug Delivery in Cardiovascular Disease: A Long Road to Nano-Cardio Medicine. Pharmaceutics 2020; 12(11): 1122 doi: 10.3390/pharmaceutics12111122
|
5 |
Tarun Pant, Nnamdi Uche, Matea Juric, Zeljko J. Bosnjak. Clinical Relevance of lncRNA and Mitochondrial Targeted Antioxidants as Therapeutic Options in Regulating Oxidative Stress and Mitochondrial Function in Vascular Complications of Diabetes. Antioxidants 2023; 12(4): 898 doi: 10.3390/antiox12040898
|